首页> 外文OA文献 >Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone

【2h】

Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone

机译：与单独使用强剂量标准化疗相比，高剂量组合烷基化剂与骨髓移植的合并可显着提高激素敏感性不敏感转移性乳腺癌完全缓解后的无病生存率。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Vredenburgh James J.; Coniglio David; Broadwater Gloria; Jones Roy B.; Ross Maureen; Shpall Elizabeth J.; Hussein Atif; Rizzieri David; Marks Larry B.; Gilbert Colleen; Affronti Mary Lou; Moore Sarah; McDonald Carolyn; Petros William P.; Peters William P.;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chemo [J] . Vredenburgh JJ, Coniglio D, Broadwater G, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2006,第2期

机译：与高剂量标准剂量化疗相比，高剂量联合烷基化剂与骨髓移植的合并可显着改善激素不敏感的转移性乳腺癌在完全缓解后的无病生存率
2. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. [J] . Stadtmauer EA, ONeill A, Goldstein LJ, The New England journal of medicine . 2000,第15期

机译：传统剂量化疗与大剂量化疗加自体造血干细胞移植治疗转移性乳腺癌的比较。费城骨髓移植小组。
3. High-dose consolidation chemotherapy with Idarubicin and alkylating agents following induction with gemcitabine-epirubicin-paclitaxel in metastatic breast cancer: a dose finding study. [J] . Bengala C, Danesi R, Guarneri V, Bone marrow transplantation . 2003,第4期

机译：吉西他滨-依比星-紫杉醇诱导转移性乳腺癌后，用依达比星和烷基化剂进行大剂量巩固化疗：一项剂量发现研究。
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Long-term follow-up of a trial comparing post-remission treatment with autologous or allogeneic bone marrow transplantation or intensive chemotherapy in younger acute myeloid leukemia patients [O] . Frédéric Baron, Fabio Efficace, Laura Cannella, 2020

机译：长期随访比较年轻急性髓细胞白血病患者缓解后治疗与自体或异体骨髓移植或强化化疗的比较
6. A randomized phase III comparative trial of immediate consolidation with high-dose chemotherapy and autologous peripheral blood progenitor cell support compared to observation with delayed consolidation in women with metastatic breast cancer and only bone metastases following intensive induction chemotherapy [O] . J J Vredenburgh, B Madan, D Coniglio, 2006

机译：与高剂量化疗和自体外周血祖细胞的立即合并的随机阶段III对比试验与患有转移性乳腺癌的延迟固结的观察和密集的诱导化疗后骨转移相比

Consolidation with High-Dose Combination Alkylating Agents with Bone Marrow Transplantation Significantly Improves Disease-Free Survival in Hormone-Insensitive Metastatic Breast Cancer in Complete Remission Compared with Intensive Standard-Dose Chemotherapy Alone

著录项

相似文献

相关主题

期刊订阅